Advanced Analytics

IntegriChain's Advanced Analytics team helps our customers develop sophisticated, custom applications of channel data for their most challenging business problems. The Advanced Analytics team combines veteran pharmaceutical market researchers, statistical expertise, and extensive hands on work with DNA information services and other secondary data assets.

Returns Forecasting and Mitigation

Advanced Analytics has developed the industry's most widely used model for forecasting returns rates for the four years following loss of patent exclusivity. Our team's model has been widely used by finance teams with blockbuster drugs going through the patent cliff. By leveraging Returns Forecasting alongside MRI, finance and trade teams have gone one step further – taking proactive action to avoid future returns.

Pharmacy Promotion ROI Analysis

Advanced Analytics regularly develops cohort-based test and control analyses of a brand's return on pharmacy promotions. See how ROI aligns by sales territory and district, and determine whether specific segments are more responsive to your product's clinical, managed care and stocking messages.

Demand Validation

Advanced Analytics team members have worked in leadership roles on several of the largest Rx brand's forecast teams. Our team members apply this knowledge to your specific products, aligning your brand's forecast inputs with ECS National and/or MRI data to identify and quantify projection errors in syndicated data or other causes of gaps between factory sales and prescription demand.

Chargeback Check-up

Task our Advanced Analytics team to use DNA's Chargeback Validation^® application on your behalf! Through Chargeback Check-up, Advanced Analytics reviews one to two years of chargeback history, across all NDCs in your portfolio, and reports back on the dollar value of actionable discrepancies contained in your chargeback data, together with specific examples for follow-up.